Evan Chen

Leukemia doc/clinical researcher @DanaFarber. Alum @StanfordMed @MGHMedicine.

[Shai Shimony @ShaiShimony]

A comprehensive, up-to-date and clinically relevant review on NPM1-mutated #AMLsm. Led by Evan_Chen, @LuskinMarlise and Richard_Stone, this is trully a clinical pearl for clinicians https://t.co/X9yg1rVmCE
@DanaFarberNews @AjHematology

[Evan Chen @Evan_ChenMD]

Many thanks @LuskinMarlise for your expert mentorship on such a timely topic. Hoping many others will find our work helpful!

[Marlise R. Luskin MD, MSCE @LuskinMarlise]

@Evan_ChenMD https://t.co/wewS6geAvm

[Marlise R. Luskin MD, MSCE @LuskinMarlise]

Neutropenia with blina may be severe, but complications usually manageable! Important to remember as blina use ↑↑↑ after recent label expansion! Congrats @Evan_ChenMD on great project: 10.1080/10428194.2024.2402808

[Marlise R. Luskin MD, MSCE @LuskinMarlise]

Severe neutropenia is associated with blinatumomab! Blina is not considered myelosuppressive, but have observed severe neutropenia. We studied 95 pts receiving blina in CR at @DanaFarber: 41% gr≥3 neutropenia, 13% ANC <100, no serious infections, not necessarily recurrent! #ALL